Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2350)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4746)
  2. Department of Medicine (4744)
  3. Center for Pancreatic Cancer Research (2313)
  4. Surgery (1066)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (221)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (321)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting HER2 (ERBB2) mutation-positive advanced biliary tract cancers with neratinib: Results from the phase II SUMMIT 'basket' trial
    Meeting Abstract

    Harding, J. J.; Cleary, J. M.; Quinn, D. I.; Braña, I.; Moreno, V.; Borad, M. J.; Loi, S.; Spanggaard, I.; Park, H.; Ford, J. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative science from CALGB 80802 (Alliance)
    Meeting Abstract

    Dercle, L.; Geyer, S. M.; Nixon, A. B.; Innocenti, F.; Shi, Q.; Jacobson, S. B.; Luk, L.; Liu, A.; Yang, H.; Wen, Y.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase Ib/II open-label, randomized evaluation of efficacy and safety of atezolizumab plus isatuximab versus regorafenib in MORPHEUS-colorectal cancer
    Meeting Abstract

    Desai, J.; Fakih, M.; Pedersen, K. S.; Hong, Y. S.; Segal, N. H.; Allen, S.; Bailey, L.; Lenain, C.; Lu, D.; Sayyed, P. Z.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Alliance/CALGB 80802: Impact of hepatitis C (HCV) on doxorubicin (DO) + sorafenib (S) versus S in patients (pts) with advanced hepatocellular carcinoma (aHCC)
    Meeting Abstract

    El Dika, I. H.; Geyer, S. M.; Nixon, A. B.; Innocenti, F.; Shi, Q.; Jacobson, S. B.; Yaqubie, A.; Lopez, J. C.; Huang, B. H.; Tang, Y. W.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Effect of FGFR2 alterations on survival in patients receiving systemic chemotherapy for intrahepatic cholangiocarcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Bibeau, K.; Schultz, N.; Yaqubie, A.; Millang, B. M.; Ren, H.; Feliz, L.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Randomized phase II trial of olaparib + pembrolizumab versus olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) mutations: SWOG S2001
    Meeting Abstract

    Chung, V.; Guthrie, K. A.; Pishvaian, M. J.; Lowy, A. M.; Chiorean, E. G.; Duong, M. T.; O'Reilly, E. M.; Philip, P. A.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Prognostic value of tumor deposits in stage III colon cancer patients, a post-hoc analysis of CALGB/SWOG 80702 phase III study
    Meeting Abstract

    Cohen, R.; Shi, Q.; Meyers, J. P.; Jin, Z.; Svrcek, M.; Fuchs, C. S.; Couture, F.; Kuebler, J. P.; Bendell, J. C.; De Jesus-Acosta, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to 177Lu-DOTATATE
    Meeting Abstract

    Coffman, K. L.; Bodei, L.; Le, T.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; Grewal, R. K.; Reddy, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Evaluation of neratinib (N), pembrolizumab (P), everolimus (E), and nivolumab (V) in patients (pts) with fibrolamellar carcinoma (FLC)
    Meeting Abstract

    Abou-Alfa, G. K.; Meyer, T.; Zhang, J.; Sherrin, S.; Yaqubie, A.; O'Neill, A. C.; Xu, F.; Eli, L. D.; Harding, J. J.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Treatment of pancreatic cancer by intra-arterial injection of an emulsion of lipiodol and bumetanide (an anti-glycolytic drug) in a transgenic mutated pig model (Oncopig)
    Meeting Abstract

    Yarmohammadi, H.; Elsakka, A.; Nurili, F.; Maxwell, A.; Ridouani, F.; Ziv, E.; O'Reilly, E.; Cheleuitte-Nieves, C.; Schook, L.; Solomon, S.; more...
    Journal of Vascular and Interventional Radiology (2021)

    Fulltext@MSK | Save